What makes aflibercept the agent of choice for diabetic eye disease?LEARN MORE

Expert comments on the 6-month results of the APOLLON study, investigating the real-world outcomes o

LEARN MORE

Jordi Monés, MD, PhD. Several agents combined with anti-VEGFs have not met expectations

LEARN MORE

Anat Loewenstein, MD, MHA gives pearls on how to manage diabetic macular edema

LEARN MORE
Older »

Error